• Coronavirus (COVID-19) Outbreak

    Latest Updates and FAQs

    Read More

  • Partnering to advance human health

    Developing and marketing pharmaceuticals globally

    Read more

  • POA Pharma is now a Galen company

    We are delighted to announce the acquisition and takeover of boutique healthcare company, POA Pharma. 

    Read the press release

  • Finding the right solutions

    By combining the greatest minds and the best resources

    Read more

  • Intelligent marketing for your product

    Comprehensively equipped to successfully champion your product to launch and sustain growth

    Read more

Galen - Developing and marketing pharmaceuticals globally

We are committed to partnering with like-minded companies to advance human health, delivering innovation, quality and value to our customers and their patients.

Galen is a privately owned pharmaceutical company established in 1968, with global headquarters in Craigavon, Northern Ireland.  It has commercial operations based in the UK, Ireland, the Nordics, Europe and the USA.

As proud member of the Almac Group of world-class companies in the pharmaceutical and biotech sectors, Galen has access to a wide variety of services, from drug discovery to commercial-scale manufacture. 

 

Availability information regarding Loestrin 20 and Loestrin 30 - Find out more

How can Galen help you?

Our specialist teams offer their expertise to help partner companies grow and expand into new markets.

  • Sales, marketing and launch excellence – we are comprehensively equipped to successfully champion your product.
  • Market access – Galen’s highly skilled team are experts at generating a positive access environment for the products it promotes.
  • Regulatory affairs, pharmacovigilance and medical affairs – a team of dedicated professionals providing key services to support the commercialisation of your products.

  • Galen is positioned to distribute products across many global regions including the UK, the Republic of Ireland (ROI), the Nordics, Europe and the USA. Its impressive reach proves an attractive proposition to potential partners.

Learn more

50+

Years of Experience

33

Current products

75+

Successfully Launched Products

25

LOCATIONS WORLDWIDE

 

Our Global Reach

United States

North America: For a full list of products currently marketed in this region, please click below
Find out more

United Kingdom

United Kingdom: For a full list of products currently marketed in this region, please click below
Find out more

Canada

Australia

Sweden

Ireland

Denmark

Iceland

Finland

Norway

Spain

Greece

Portugal

Italy

Colombia

India

Israel

Czech Republic

Slovakia

Turkey

Singapore

Malaysia

South Africa

  • United States

    North America: For a full list of products currently marketed in this region, please click below
    Find out more

  • United Kingdom

    United Kingdom: For a full list of products currently marketed in this region, please click below
    Find out more

  • Canada

  • Australia

  • Sweden

  • Ireland

  • Denmark

  • Iceland

  • Finland

  • Norway

  • Spain

  • Greece

  • Portugal

  • Italy

  • Colombia

  • India

  • Israel

  • Czech Republic

  • Slovakia

  • Turkey

  • Singapore

  • Malaysia

  • South Africa

  • United States
  • Canada
  • Columbia
  • Iceland
  • Ireland
  • United Kingdom
  • Portugal
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Finland
  • Czech Republic
  • Slovakia
  • Italy
  • Greece
  • Turkey
  • Israel
  • South Africa
  • India
  • Singapore
  • Malaysia
  • Australia
  • United States
  • Canada
  • Columbia
  • Iceland
  • Ireland
  • United Kingdom
  • Portugal
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Finland
  • Czech Republic
  • Slovakia
  • Italy
  • Greece
  • Turkey
  • Israel
  • South Africa
  • India
  • Singapore
  • Malaysia
  • Australia

Latest News

Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments

Inhaled analgesic can save average patient 71 minutes for some common injuries compared to...

Call for entries for the Dr John Hinds Scholarship

Call for entries for the Dr John Hinds Scholarship Craigavon, N.I., 3 Mar 2020 – The College...

Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK

Launch of innovative medical food provides a palatable new option for people diagnosed with rare...
MAT-GAL-UK-000054 
Date of Preparation: August 2019

Would you like to discuss how Galen can help you?

If you would like to explore how Galen’s expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.

Contact Us